Alzheimer's

Lilly licenses AlzeCure Alzheimer’s asset for $1B biobucks

Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease for up to $1 billion biobucks.

Will Maddox Jun 9, 2026 10:16am

Study finds blood test can predict age of Alzheimer's onset

Feb 19, 2026 7:20am

GSK inks 5-year deal with Jackson Lab for neuro research

Feb 18, 2026 3:30pm

Lightbulb with an image of a brain inside

Labcorp launches Roche's FDA-cleared Alzheimer's blood test

Feb 12, 2026 7:15am

Quanterix nabs Illumina’s CCO as new leader

Jan 9, 2026 10:45am

Sanofi signs 2nd biotech deal of the day

Dec 15, 2025 5:50pm